4//SEC Filing
Arthur David J. 4
Accession 0001615219-22-000087
CIK 0001615219other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 5:17 PM ET
Size
10.8 KB
Accession
0001615219-22-000087
Insider Transaction Report
Form 4
Arthur David J.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-05-26$0.18/sh+708$127→ 282,382 total(indirect: By son) - Purchase
Common Stock
2022-05-26$0.18/sh+3,400$612→ 263,074 total - Purchase
Common Stock
2022-05-26$0.18/sh+18,600$3,385→ 281,674 total - Purchase
Common Stock
2022-05-26$0.18/sh+10,392$1,870→ 292,774 total(indirect: By son) - Purchase
Common Stock
2022-05-26$0.18/sh+10,800$1,990→ 303,574 total(indirect: By daughter)
Footnotes (1)
- [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001769331
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 5:17 PM ET
- Size
- 10.8 KB